These findings are consistent with those reported in previous studies regarding both the frequency of mutations and the different spectrum of FLT3 mutations in B-cell acute lymphoblastic leukemia (B-ALL) compared to AML (20, 21). The gene discussed is FLT3; the disease is B-cell acute lymphoblastic leukemia.